ProfileGDS4459 / ENSG00000131379
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 27% 18% 26% 10% 23% 22% 24% 21% 19% 17% 24% 26% 23% 6% 22% 19% 39% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.6427
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.3518
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.326
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 42.9810
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.2823
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.3322
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.2224
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.0721
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.9119
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 102.917
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.3624
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.3226
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.2223
GSM623477group B, liver allograft wedge biopsie placebo treatment 42.686
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.0622
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.3419
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.0439